Connect with us

Technology

Global Clinical Chemistry Analyzers Market Poised to Reach US$ 19.02 Billion by 2030 Amid Technological Advancements in Healthcare

Published

on

DUBLIN, Feb. 23, 2024 /PRNewswire/ — The “Clinical Chemistry Analyzers Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis” report has been added to  ResearchAndMarkets.com’s offering.

The global clinical chemistry analyzers market is forecasted to witness significant growth, with projections indicating an ascent to US$ 19.02 Billion by 2030. This robust expansion reflects a compound annual growth rate (CAGR) of 4.35% during the analysis period of 2023-2030. Such an upward trajectory is fueled by the rising prevalence of chronic diseases, surging health awareness, and the unparalleled advancements in healthcare technology that enhance the effectiveness of diagnostic tools and broaden the capabilities of clinical chemistry analyzers.

In the Spotlight: The Crucial Role of Reagents in Advance Diagnostics

The clinical chemistry analyzer segment of reagents stands as the foremost contributor to market dominance. These integral components of clinical chemistry analyzers are indispensable in the realm of medical diagnostics, enabling the precise detection and quantification of various biomarkers crucial for patient care. Their inimitability lies in their capacity to conduct accurate diagnostic assessments, propelling the reagents market to an unwavering position at the forefront of clinical research and diagnostics.

Basic Metabolic Panel (BMP) – Dominating the Diagnostic Landscape

An extensive analysis reveals that the Basic Metabolic Panel (BMP) dominates the clinical chemistry analyzer industry. BMP’s universal application in monitoring vital metabolic indicators enables healthcare practitioners to swiftly gauge and manage an array of metabolic dysfunctions and chronic illnesses. As healthcare systems pivot towards preventative healthcare, the value of BMPs in diagnostics is reinforced, thereby maintaining its significance within the medical chemistry analyzer arena.

Hospital Laboratories Leading in Clinical Chemistry Analyzer Usage

The clinical chemistry analyzers industry endows hospitals with a remarkable market share, cementing their stature as central to patient diagnosis, treatment planning, and continuous monitoring. Ensuring precise biomarker measurements, these analyzers are fundamental to hospital labs, aiding healthcare professionals in making critical care decisions and enhancing the precision of diagnostic and therapeutic methods.

United States: A Hub for Clinical Chemistry Analyzer Excellence

In the geographical dissection of the clinical chemistry analyzer market, the United States stands out as a nexus of innovation, leading the industry with technological sophistication and a robust presence. The U.S. healthcare sector’s commitment to developing superior healthcare solutions mirrors in the production of advanced clinical chemistry analyzers that satisfy the sophisticated demands of modern healthcare provision, cementing the U.S. as a powerhouse within the global healthcare apparatus.

Key Players

Thermo Fisher ScientificAbbott LaboratoriesSiemens HealthineersDanaher CorporationJohnson & JohnsonSysmex ADRHORIBA LtdHitachi

Product Type

AnalyzersReagentsOthers

Test Type

Basic Metabolic PanelLiver PanelRenal ProfileLipid ProfileThyroid Function PanelElectrolyte PanelSpecialty Chemical tests

End User

HospitalsDiagnostic LaboratoriesResearch Laboratories & InstitutesOthers

Region

North AmericaUnited StatesCanadaEuropeGermanyUnited KingdomFranceItalyNetherlandsSpainAsia PacificChinaSouth KoreaJapanIndiaIndonesiaMalaysiaAustraliaLatin AmericaArgentinaBrazilMexicoColombiaMiddle East & AfricaSaudi ArabiaUAEIsraelSouth AfricaRest of World

For more information about this report visit https://www.researchandmarkets.com/r/plhihq

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/global-clinical-chemistry-analyzers-market-poised-to-reach-us-19-02-billion-by-2030-amid-technological-advancements-in-healthcare-302069942.html

SOURCE Research and Markets

Continue Reading

Technology

EBSCO Clinical Decisions Appoints Paul Tuten as Executive Vice President

Published

on

By

~ Seasoned health IT executive and former ONC advisor to lead EBSCO Clinical Decisions as it advances its mission to bring trusted evidence to clinicians at the point of care.~

IPSWICH, Mass., Oct. 26, 2026 /PRNewswire/ — EBSCO Clinical Decisions today announced the appointment of Paul Tuten as its Executive Vice President. In his role, Tuten will oversee all aspects of EBSCO Clinical Decisions, including strategy, content, product development, and growth. His priorities include advancing the organization’s point-of-care strategy and expanding partnerships that bring expert-vetted DynaMed® content directly into the workflows, platforms, and AI-enabled tools clinicians use every day.

“Paul’s strong and even-handed leadership is an incredible asset as we work to deliver intelligent, evidence-based tools that elevate care delivery,” said Roy Ziegelstein, MD, MACP, Editor-in-Chief and Chief Medical Officer of DynaMed. “His deep technical expertise and track record in academic publishing will help us take the next step in building and delivering trustworthy, evidence-based solutions for clinicians that integrate natively into their daily workflows, reducing friction and improving care when and where it matters most.”

Tuten joined the company in 2025 as Executive Vice President and Chief Platform Officer at EBSCO Information Services, focused on accelerating scalable growth of EBSCO’s advanced knowledge services. Prior to joining, he was Chief Product and Technology Officer at Taylor & Francis, where he led a global team in driving digital transformation and enhancing data governance, analytics, and platform-centric customer experiences in service to academic researchers. Tuten previously built and repositioned health IT organizations focused on clinical data exchange, patient safety, quality measurement, and revenue cycle management, including at Quantros (now part of RLDatix and Healthcare Bluebook), RxAnte, and ABILITY Network (now part of Inovalon). He holds a PhD in Information Systems from Nova Southeastern University.

“For too long, clinical decision support has worked like a paper map. Useful, but only if you pull over to review it and already know where you are. Clinicians need something closer to GPS, seamlessly integrated into the car and proactively guiding them in real time without having to take their eyes off the road,” said Tuten. “At EBSCO Clinical Decisions, our job is to get trusted clinical knowledge everywhere care is delivered. But like GPS, clinical decision support is only as good as the information behind it. With AI tools multiplying and published research outpacing peer review, it’s never mattered more that human experts decide what evidence informs it. I’m excited to help bring this vision to life and set a new standard for point-of-care delivery.”

Tuten has also advised the federal government on health information exchange and interoperability as a Senior Advisor to the Office of the National Coordinator for Health Information Technology (ONC) at the U.S. Department of Health and Human Services. In that role, he supported the HITECH Act’s Meaningful Use program and served as a government liaison to EHR vendors on certification criteria.

To learn more about EBSCO Clinical Decisions, click here. 

About EBSCO Clinical Decisions

EBSCO Information Services (EBSCO) helps people find, access, and apply trusted information. Through its EBSCO Clinical Decisions suite of products, EBSCO delivers evidence-based clinical decision-support solutions designed to help healthcare professionals answer clinical questions, support informed decisions, and improve patient care.

EBSCO Clinical Decisions combines trusted clinical content with advanced technologies to support healthcare organizations and clinicians across clinical decision-making, patient care, learning, and research. The suite is designed to provide current, evidence-based information within the clinical workflow, helping healthcare professionals find the answers they need when they need them. For more information, visit www.clinicaldecisions.com. Visit our blog at Health Notes or follow us on X and LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ebsco-clinical-decisions-appoints-paul-tuten-as-executive-vice-president-302918867.html

SOURCE EBSCO Information Services

Continue Reading

Technology

College Board Launches AP Cybersecurity to Prepare Students to Protect the Digital World

Published

on

By

New high school course builds foundational skills for college, careers, and service as states connect cybersecurity education to national security needs

NEW YORK, Oct. 26, 2026 /PRNewswire/ — Cyber threats reach into everyday life, from scams that steal families’ savings to attacks on utilities and other essential services. Helping students understand and respond to those threats can open doors to further education, employment, and national defense service. College Board’s new AP Cybersecurity course, which was launched in high schools this fall, gives students a place to begin.

In 2025, U.S. employers posted more than half a million job listings requiring cybersecurity skills. Yet many students have little opportunity to learn about cybersecurity in high school or see where those skills could take them.

Experience the full interactive Multichannel News Release here: https://www.multivu.com/college_board/9381153-en-college-board-launches-ap-cybersecurity

AP Cybersecurity introduces students to the work behind that demand: protecting the systems people depend on. Through practical scenarios, students assess security weaknesses, weigh risks, and investigate evidence of attacks. An assignment might ask them to evaluate threats to internet-connected farm equipment or recommend protections for computer networks aboard a naval submarine.

These assignments help students see how cybersecurity skills apply across industries and in national defense. Indiana offers an example of how those connections can take shape. The statewide Cybersecurity Partnership brings together high schools, colleges, employers, and the Indiana National Guard to help students explore routes into further education, employment, and military service.

The course and partnerships like Indiana’s address two connected needs: giving students an introduction to cybersecurity and helping them understand where continued learning could lead. For students, that connection gives classroom assignments a larger purpose. Investigating a security weakness today can be a first step toward learning how to protect a hospital, secure a business, or defend the country.

Interested in learning more? Talk to your school district or high school to see if they are offering AP Cybersecurity or visit collegeboard.org

View original content:https://www.prnewswire.com/news-releases/college-board-launches-ap-cybersecurity-to-prepare-students-to-protect-the-digital-world-302918558.html

SOURCE College Board

Continue Reading

Technology

Alkami to Host Webinar with Thomaston Savings Bank on Using Predictive AI to Deliver Data-Driven Guidance and Accelerate Growth

Published

on

By

Leaders from Alkami and Thomaston Savings Bank will discuss how financial institutions can use predictive AI and behavioral signals to drive strategic growth and strengthen account holder relationships

PLANO, Texas, Oct. 26, 2026 /PRNewswire/ — Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami”), a digital sales and service platform provider for financial institutions in the U.S., today announced an upcoming webinar hosted with Thomaston Savings Bank, “Guess Less and Grow More with Predictive AI.” The webinar will take place Wednesday, October 28, 2026, at 2 p.m. ET.

As account holders increasingly expect more personalized and proactive experiences, financial institutions have an opportunity to leverage data to deliver tailored guidance during every interaction. According to Alkami research, 44% of Americans who use digital banking wish their primary financial provider did a better job anticipating their financial needs and goals.1

The upcoming webinar will explore how financial institutions can respond to these expectations by using predictive artificial intelligence (AI) to drive growth across deposits and lending while strengthening primary relationships. Speakers will discuss how Alkami’s Data & Marketing Solution uses behavioral insights and predictive AI to help institutions identify growth opportunities and deliver more personalized outreach.

Featured speakers include:

Kent Blacksher, strategic account executive, AlkamiEthan O’Day, business intelligence analyst, Thomaston Savings Bank

“Data helps us understand how customers engage, but the real value comes from understanding what those behaviors may tell us about their needs,” said Ethan O’Day, business intelligence analyst, Thomaston Savings Bank. “Predictive AI can help us focus our outreach sooner and make it more relevant, while our team’s expertise keeps the work grounded in the relationships we have with our customers.”

During the session, attendees will learn how to:

Identify deposit and lending opportunities using behavioral signalsCreate more relevant outreach for customers and membersRecognize engagement and attrition signals earlierSimplify campaign execution and move from insight to actionBuild marketing strategies that support growth and retention

The presentation will explore real examples of how data-activated campaigns drive faster product adoption, along with insights into how predictive AI can help guide your team’s strategy.

“Financial institutions have more data than ever, but data creates value when teams can turn insight into action,” said Kent Blacksher, strategic account executive at Alkami. “Combining predictive AI with human expertise allows marketing teams to skip the guesswork while building stronger account holder relationships.”

To register for the webinar, visit here.

To learn more about Anticipatory Banking and the Alkami Digital Sales & Service Platform, visit here.

About Alkami
Alkami provides a digital sales and service platform for U.S. banks and credit unions. Our unified Platform integrates onboarding, digital banking, and data and marketing—each solution can stand alone, but together they deliver more—to help institutions onboard, engage, and grow relationships. As the future shifts toward Anticipatory Banking, we help data-informed bankers meet the moment with technology that drives action.

1 Alkami Proprietary Research. 2026 Digital Banking Americans Research Study. Online survey of 1,500 U.S. digital banking Americans conducted March 26–April 22, 2026.

Media Relations Contacts
Vested
alkami@fullyvested.com

Marla Pieton
marla.pieton@alkami.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/alkami-to-host-webinar-with-thomaston-savings-bank-on-using-predictive-ai-to-deliver-data-driven-guidance-and-accelerate-growth-302918495.html

SOURCE Alkami Technology, Inc.

Continue Reading

Trending